Rena Denoncourt

Pharma leaders on embracing nonlinear careers, leading inclusively, and preserving a distinct voice as AI-generated content becomes the norm.

Pharma leaders on building networks, asking for stretch opportunities, and approaching AI and remote work with curiosity and confidence.

Pharma leaders on why AI safety must be designed in from the start—and why human oversight is non-negotiable when patients are affected.

Pharma leaders on building cultures where high performance and human connection coexist—and how shared mission drives progress in complex disease.

Pharma leaders on why shared purpose and authentic human connection remain the foundation of effective leadership as digital tools advance.

Pharma leaders on redesigning workflows for agility—and how AI is compressing timelines and reshaping roles across tech, marketing, and MLR.

Pharma leaders on balancing discipline and flexibility—and staying consistent in strengths and values as business contexts constantly shift.

Pharma leaders on building trust in AI through transparency and validation—and helping teams adapt as analytics roles evolve with the technology.

Pharma leaders on navigating agentic AI without a playbook—and keeping patient and physician benefit as the north star through uncertainty.

Pharma leaders on building global strategy from a product’s universal truth—then adapting locally and adjusting plans as new data emerges.

Pharma leaders on sitting with uncertainty before acting—and tailoring communication to resonate with investors and scientific audiences alike.

Pharma leaders on building teams with rigor and trust—and retaining talent by connecting individual growth to mission and patient impact.

Pharma leaders share how trust, mission alignment, and guiding teams through rapid change—including AI—drive results for patients.